Cargando…
Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women
BACKGROUND: Algorithms that bridge the gap between syndromic sexually transmitted infection (STI) management and treatment based in realistic diagnostic options and local epidemiology are urgently needed across Africa. Our objective was to develop and validate a risk algorithm for Neisseria gonorrho...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080377/ https://www.ncbi.nlm.nih.gov/pubmed/33910514 http://dx.doi.org/10.1186/s12879-021-06073-z |
_version_ | 1783685413041340416 |
---|---|
author | Wall, Kristin M. Nyombayire, Julien Parker, Rachel Ingabire, Rosine Bizimana, Jean Mukamuyango, Jeannine Mazzei, Amelia Price, Matt A. Unyuzimana, Marie Aimee Tichacek, Amanda Allen, Susan Karita, Etienne |
author_facet | Wall, Kristin M. Nyombayire, Julien Parker, Rachel Ingabire, Rosine Bizimana, Jean Mukamuyango, Jeannine Mazzei, Amelia Price, Matt A. Unyuzimana, Marie Aimee Tichacek, Amanda Allen, Susan Karita, Etienne |
author_sort | Wall, Kristin M. |
collection | PubMed |
description | BACKGROUND: Algorithms that bridge the gap between syndromic sexually transmitted infection (STI) management and treatment based in realistic diagnostic options and local epidemiology are urgently needed across Africa. Our objective was to develop and validate a risk algorithm for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) diagnosis among symptomatic Rwandan women and to compare risk algorithm performance to the current Rwandan National Criteria for NG/CT diagnosis. METHODS: The risk algorithm was derived in a cohort (n = 468) comprised of symptomatic women in Kigali who sought free screening and treatment for sexually transmitted infections and vaginal dysbioses at our research site. We used logistic regression to derive a risk algorithm for prediction of NG/CT infection. Ten-fold cross-validation internally validated the risk algorithm. We applied the risk algorithm to an external validation cohort also comprised of symptomatic Rwandan women (n = 305). Measures of calibration, discrimination, and screening performance of our risk algorithm compared to the current Rwandan National Criteria are presented. RESULTS: The prevalence of NG/CT in the derivation cohort was 34.6%. The risk algorithm included: age < =25, having no/primary education, not having full-time employment, using condoms only sometimes, not reporting genital itching, testing negative for vaginal candida, and testing positive for bacterial vaginosis. The model was well calibrated (Hosmer-Lemeshow p = 0.831). Higher risk scores were significantly associated with increased prevalence of NG/CT infection (p < 0.001). Using a cut-point score of > = 5, the risk algorithm had a sensitivity of 81%, specificity of 54%, positive predictive value (PPV) of 48%, and negative predictive value (NPV) of 85%. Internal and external validation showed similar predictive ability of the risk algorithm, which outperformed the Rwandan National Criteria. Applying the Rwandan National Criteria cutoff of > = 2 (the current cutoff) to our derivation cohort had a sensitivity of 26%, specificity of 89%, PPV of 55%, and NPV of 69%. CONCLUSIONS: These data support use of a locally relevant, evidence-based risk algorithm to significantly reduce the number of untreated NG/CT cases in symptomatic Rwandan women. The risk algorithm could be a cost-effective way to target treatment to those at highest NG/CT risk. The algorithm could also aid in sexually transmitted infection risk and prevention communication between providers and clients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06073-z. |
format | Online Article Text |
id | pubmed-8080377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80803772021-04-29 Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women Wall, Kristin M. Nyombayire, Julien Parker, Rachel Ingabire, Rosine Bizimana, Jean Mukamuyango, Jeannine Mazzei, Amelia Price, Matt A. Unyuzimana, Marie Aimee Tichacek, Amanda Allen, Susan Karita, Etienne BMC Infect Dis Research BACKGROUND: Algorithms that bridge the gap between syndromic sexually transmitted infection (STI) management and treatment based in realistic diagnostic options and local epidemiology are urgently needed across Africa. Our objective was to develop and validate a risk algorithm for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) diagnosis among symptomatic Rwandan women and to compare risk algorithm performance to the current Rwandan National Criteria for NG/CT diagnosis. METHODS: The risk algorithm was derived in a cohort (n = 468) comprised of symptomatic women in Kigali who sought free screening and treatment for sexually transmitted infections and vaginal dysbioses at our research site. We used logistic regression to derive a risk algorithm for prediction of NG/CT infection. Ten-fold cross-validation internally validated the risk algorithm. We applied the risk algorithm to an external validation cohort also comprised of symptomatic Rwandan women (n = 305). Measures of calibration, discrimination, and screening performance of our risk algorithm compared to the current Rwandan National Criteria are presented. RESULTS: The prevalence of NG/CT in the derivation cohort was 34.6%. The risk algorithm included: age < =25, having no/primary education, not having full-time employment, using condoms only sometimes, not reporting genital itching, testing negative for vaginal candida, and testing positive for bacterial vaginosis. The model was well calibrated (Hosmer-Lemeshow p = 0.831). Higher risk scores were significantly associated with increased prevalence of NG/CT infection (p < 0.001). Using a cut-point score of > = 5, the risk algorithm had a sensitivity of 81%, specificity of 54%, positive predictive value (PPV) of 48%, and negative predictive value (NPV) of 85%. Internal and external validation showed similar predictive ability of the risk algorithm, which outperformed the Rwandan National Criteria. Applying the Rwandan National Criteria cutoff of > = 2 (the current cutoff) to our derivation cohort had a sensitivity of 26%, specificity of 89%, PPV of 55%, and NPV of 69%. CONCLUSIONS: These data support use of a locally relevant, evidence-based risk algorithm to significantly reduce the number of untreated NG/CT cases in symptomatic Rwandan women. The risk algorithm could be a cost-effective way to target treatment to those at highest NG/CT risk. The algorithm could also aid in sexually transmitted infection risk and prevention communication between providers and clients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06073-z. BioMed Central 2021-04-28 /pmc/articles/PMC8080377/ /pubmed/33910514 http://dx.doi.org/10.1186/s12879-021-06073-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wall, Kristin M. Nyombayire, Julien Parker, Rachel Ingabire, Rosine Bizimana, Jean Mukamuyango, Jeannine Mazzei, Amelia Price, Matt A. Unyuzimana, Marie Aimee Tichacek, Amanda Allen, Susan Karita, Etienne Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title | Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title_full | Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title_fullStr | Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title_full_unstemmed | Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title_short | Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women |
title_sort | developing and validating a risk algorithm to diagnose neisseria gonorrhoeae and chlamydia trachomatis in symptomatic rwandan women |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080377/ https://www.ncbi.nlm.nih.gov/pubmed/33910514 http://dx.doi.org/10.1186/s12879-021-06073-z |
work_keys_str_mv | AT wallkristinm developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT nyombayirejulien developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT parkerrachel developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT ingabirerosine developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT bizimanajean developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT mukamuyangojeannine developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT mazzeiamelia developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT pricematta developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT unyuzimanamarieaimee developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT tichacekamanda developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT allensusan developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen AT karitaetienne developingandvalidatingariskalgorithmtodiagnoseneisseriagonorrhoeaeandchlamydiatrachomatisinsymptomaticrwandanwomen |